
|Slideshows|August 14, 2014
5 Things You May Not Know About Multiple Sclerosis
Author(s)Leo Robert
Here: succinct highlights from new studies may offer you insights about multiple sclerosis you didn't have before.
Advertisement
MS and cigarettes; statins and secondary progressive MS; transitioning from Tysabri in JC+ recipients; cerebrospinal venous insufficiency and MS; and marijuana for MS symptoms. . . Here: key points from 5 new studies that you might have missed.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5










